Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs).
OBJECTIVE
Our purpose was to develop a geographically localized, multi-institution strategy for improving enrolment in a trial of secondary stroke prevention.


METHODS
We invited 11 Connecticut hospitals to participate in a project named the Local Identification and Outreach Network (LION). Each hospital provided the names of patients with stroke or TIA, identified from electronic admission or discharge logs, to researchers at a central coordinating center. After obtaining permission from personal physicians, researchers contacted each patient to describe the study, screen for eligibility, and set up a home visit for consent. Researchers traveled throughout the state to enroll and follow participants. Outside the LION, investigators identified trial participants using conventional recruitment strategies. We compared recruitment success for the LION and other sites using data from January 1, 2005, through June 30, 2007.


RESULTS
The average monthly randomization rate from the LION was 4.0 participants, compared with 0.46 at 104 other Insulin Resistance Intervention after Stroke (IRIS) sites. The LION randomized on average 1.52/1,000 beds/month, compared with 0.76/1,000 beds/month at other IRIS sites (p = 0.03). The average cost to randomize and follow one participant was $8,697 for the LION, compared with $7,198 for other sites.


CONCLUSIONS
A geographically based network of institutions, served by a central coordinating center, randomized substantially more patients per month compared with sites outside of the network. The high enrollment rate was a result of surveillance at multiple institutions and greater productivity at each institution. Although the cost per patient was higher for the network, compared with nonnetwork sites, cost savings could result from more rapid completion of research.
Departments of Internal Medicine, Yale School of Medicine, New Haven, CT 06519, USA. walter.kernan@yale.edu
W N
WN
Kernan
C M
CM
Viscoli
D
D
Demarco
B
B
Mendes
K
K
Shrauger
J L
JL
Schindler
J C
JC
McVeety
A
A
Sicklick
D
D
Moalli
P
P
Greco
D M
DM
Bravata
S
S
Eisen
L
L
Resor
K
K
Sena
D
D
Story
L M
LM
Brass
K L
KL
Furie
L
L
Gutmann
E
E
Hinnau
M
M
Gorman
A M
AM
Lovejoy
S E
SE
Inzucchi
L H
LH
Young
R I
RI
Horwitz
D002986:Clinical Trials as Topic / Q000379:methods*; D003237:Connecticut; D006764:Hospitals, Community; D006801:Humans; D007258:Informed Consent; D007333:Insulin Resistance; D002546:Ischemic Attack, Transient / Q000517:prevention & control; D015337:Multicenter Studies as Topic; D009422:Nervous System Diseases / Q000628:therapy*; D009462:Neurology / Q000458:organization & administration*; D018579:Patient Selection; D011897:Random Allocation; D020521:Stroke / Q000517:prevention & control